Clinical trial
Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the…
NCT00144157 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00144157 |
|---|---|
| Title | Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV |
| Official title | An Open-Label Study of Nevirapine Plus Combivir® (ZDV+3TC) Treatment in Women Who Have Previously Received a Nevirapine Regimen for the Prevention of Mother to Child Transmission (pMTCT) of HIV-1. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome |
| Intervention type | Drug |
| Interventions | Nevirapine, Zidovudine, 3TC |
| Enrollment | 53 |
| Start date | Jun 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Nov 14, 2013 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: